Sustainability

Created by global index provider FTSE Russell, the FTSE Blossom Japan Sector Relative Index reflects the performance of Japanese companies that demonstrate strong environmental, social and governance (ESG) practices relative to their respective sectors and is designed to be sector neutral.In addition, to facilitate the transition to a low-carbon economy, it includes only those companies whose improvement efforts are evaluated by the TPI (Transition Pathway Initiative) Management Quality Score, especially for companies with high greenhouse gas emissions.

FTSE Russell (registered trademark of FTSE International Limited and Frank Russell Company) hereby certifies that Hisamitsu Pharmaceutical, as a result of a third-party survey, has met the requirements for inclusion in the FTSE Blossom Japan Sector Relative Index and has become a constituent of the index. The FTSE Blossom Japan Sector Relative Index is widely used to create and evaluate sustainable investment funds and other financial products.

The universe for the S&P/JPX Carbon Efficient Index is TOPIX, a representative stock price index that shows trends in the Japanese market. The S&P/JPX Carbon Efficient Index determines the weighting of the constituent stocks by focusing on those companies' levels of environmental information disclosure and carbon efficiency (carbon emissions per unit of revenue). By adopting rules such as overweighting the companies that sufficiently disclose environmental information and have high carbon efficiency (low carbon emissions per unit of revenue), the S&P/JPX Carbon Efficient Index encourages environmental initiatives and information disclosure across the market and aims to revitalize the stock market.

The NIKKEI Sustainable Management Survey, SDGs Edition, conducted by Nikkei Inc. since 2019, rates companies’ commitment to the Sustainable Development Goals (SDGs) in the four categories of “SDGs strategy/economic value,” “social value,” “environmental value,” and “governance.” The score of each company is converted into a deviation value, and a deviation value of 70 or higher is set as 5.0 stars. For lower deviations, the rating changes by 0.5 stars in increments of five deviation values.
Hisamitsu Pharmaceutical was certified with three stars in the Nikkei SDGs Management Survey 2024.

DX Certification is a system by which the Ministry of Economy, Trade and Industry certifies companies based on the Act on Facilitation of Information Processing. This certification is granted to companies that are deemed ready to promote digital transformation and meet the basic requirements specified in the Digital Governance Code, which summarizes how business managers are required to respond to social changes caused by digital technology.
We obtained DX Certification in May 2024.

The Declaration of Partnership Building is a framework established by the Council on Promoting Partnership Building for Cultivating the Future, whose members include the Chairman of KEIDANREN (Japan Business Federation), the Chairman of the Japan Chamber of Commerce and Industry, the President of RENGO (the Japanese Trade Union Confederation), and relevant ministers (the Cabinet Office, Ministry of Economy, Trade and Industry, Ministry of Health, Labour and Welfare, Ministry of Agriculture, Forestry and Fisheries, and Ministry of Land, Infrastructure, Transport and Tourism). Companies make this Declaration in the name of their representatives from the perspective of the ordering party to show their determination to build new partnerships through the promotion of collaboration, coexistence, and mutual prosperity with business partners in the supply chain and business operators seeking to create value. In 2023, we published our Declaration on the Declaration of Partnership Building Portal Site.